Archive · 19 Aug 2025
Supreme Court Dismisses IMA Petition on Patanjali Ads
The Supreme Court decided that the Indian Medical Association (IMA) could not stop Patanjali from advertising their products.
The IMA was upset because they thought Patanjali’s ads were misleading about modern medicine.
A rule that controlled how AYUSH medicines (like Ayurveda) were advertised was also a part of the case.
The government removed this rule, but then the court briefly brought it back.
However, the court said that the states could not use this rule since the central government removed it.
The court had also looked at Patanjali's ads before and closed contempt proceedings against Patanjali after apologies.
The Supreme Court dismissed the IMA's petition against Patanjali's misleading ads.
The IMA's petition was related to Patanjali Ayurved’s advertisements and their impact on modern medicine.
Rule 170, which regulated the advertising of AYUSH medicines, was a point of contention.
The AYUSH Ministry initially removed Rule 170, but the Supreme Court temporarily restored it.
The court determined that states cannot enforce a rule removed by the Centre.
- Who
- The Indian Medical Association (IMA) and Patanjali Ayurved.
- What
- The Supreme Court dismissed a petition by the IMA against Patanjali Ayurved's advertisements.
- When
- The Supreme Court's decision was made on August 11, 2025.
- Where
- The Supreme Court.
- Why
- The IMA sought to address what it perceived as misleading advertisements by Patanjali.
Indian Medical Association (IMA)
Patanjali Ayurved
Misleading Advertisements
Indian Medical Association (IMA)
IMA felt Patanjali's advertisements misled consumers and negatively affected modern medicine.
Patanjali Ayurved
Patanjali's ads are not misleading. The ads were not specified.
- Court Decision Date
- August 11, 2025
- Petitioner
- Indian Medical Association (IMA)
- Respondent
- Patanjali Ayurved
- Key Issue
- Misleading advertisements and Rule 170
- Related Ministry
- AYUSH Ministry